公司概覽
業務類別 --
業務概覽 Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medicalsegment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such asvials and syringes. Nipro generates the majority of its revenue in Japan.
公司地址 3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
電話號碼 +81 663722331
傳真號碼 +81 663750669
公司網頁 http://www.nipro.co.jp
員工數量 30461
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Tsuyoshi Yamazaki Director and President -- 25/06/2025
Mr. Hideto Nakamura Director, General Manager, General Affairs and Human Resources Department and General Manager, Governance Supervisory Department -- 25/06/2025
Mr. Kimihito Minoura Director, Managing Director, General Manager, Business Promotion Department, General Manager, Business Administration Headquarters and General Manager of New Business Development Division -- 25/06/2025
Mr. Taku Nikaido Director, Executive Officer, Executive General Manager, Medical Instruments Development and Technical Sales Headquarters and Executive General Manager, Medical Instruments Development and Technical Sales Headquarters, Global Business Division -- 25/06/2025
Mr. Goichi Miyazumi Director, Senior Executive Officer and Deputy Division Manager, Global Business Division -- 25/06/2025
Mr. Kaname Sadahiro Director, Senior Executive Officer, Executive General Manager, Global Product Development and Sales Headquarters, Global Business Division, General Manager, Dialysis and Blood Purification Product Development and Technical Sales Department and General Man -- 25/06/2025
Mr. Atsushi Yoneda Director, Executive Officer and General Manager, Operation Department, Production Technology Center -- 25/06/2025
Mr. Hideyuki Nishisako Director and Executive Officer -- 25/06/2025
Mr. Takehito Yogo Director, Senior Managing Director and General Manager, Corporate Planning Headquarters, Administrative Control -- 25/06/2025
Mr. Yasushi Ohyama Director, Managing Director and General Manager, Vascular Division -- 25/06/2025
Mr. Kenichi Nishida Director, Managing Director and General Manager, Pharmaceutical Manufacturing and Administration Division -- 25/06/2025
 
董事會成員
董事會 職務 更新日期
Mr. Yoshihiko Sano Chairman of the Board 25/06/2025
Ms. Yoshiko Tanaka Independent Director 25/06/2025
Mr. Tsuyoshi Yamazaki Director and President 25/06/2025
Mr. Toshiaki Hattori Independent Director 25/06/2025
Mr. Toshikazu Yoshimori Independent Director 25/06/2025
Mr. Hideto Nakamura Director, General Manager, General Affairs and Human Resources Department and General Manager, Governance Supervisory Department 25/06/2025
Mr. Kimihito Minoura Director, Managing Director, General Manager, Business Promotion Department, General Manager, Business Administration Headquarters and General Manager of New Business Development Division 25/06/2025
Mr. Taku Nikaido Director, Executive Officer, Executive General Manager, Medical Instruments Development and Technical Sales Headquarters and Executive General Manager, Medical Instruments Development and Technical Sales Headquarters, Global Business Division 25/06/2025
Mr. Goichi Miyazumi Director, Senior Executive Officer and Deputy Division Manager, Global Business Division 25/06/2025
Ms. Yuka Kushida Independent Director 25/06/2025
Mr. Yasuhiko Imaizumi Independent Director 25/06/2025
Mr. Kaname Sadahiro Director, Senior Executive Officer, Executive General Manager, Global Product Development and Sales Headquarters, Global Business Division, General Manager, Dialysis and Blood Purification Product Development and Technical Sales Department and General Man 25/06/2025
Mr. Atsushi Yoneda Director, Executive Officer and General Manager, Operation Department, Production Technology Center 25/06/2025
Mr. Hideyuki Nishisako Director and Executive Officer 25/06/2025
Ms. Yoshiko Shimamori Independent Director 25/06/2025
Mr. Takehito Yogo Director, Senior Managing Director and General Manager, Corporate Planning Headquarters, Administrative Control 25/06/2025
Mr. Yasushi Ohyama Director, Managing Director and General Manager, Vascular Division 25/06/2025
Mr. Kenichi Nishida Director, Managing Director and General Manager, Pharmaceutical Manufacturing and Administration Division 25/06/2025
 
所屬ETF (更新日期: 07/03/2026 04:33)
代號 名稱 佔比% 持有日期
DFJWisdomTree Japan SmallCap Dividend ETF0.02%27/02/2026
SCJiShares MSCI Japan Small-Cap ETF0.02%28/02/2026
VSGXVanguard ESG International Stock ETF0.02%31/01/2026
PDNInvesco RAFI Developed Mkts ex-US S-METF0.02%24/02/2026
AGNGGlobal X Aging Population ETF0.01%27/02/2026
DDLSWisdomTree Dynamic Intl SmCap Eq ETF0.01%27/02/2026
AVDSAvantis International Small Cp Eq ETF0.01%28/02/2026
AVSDAvantis Responsible International Eq ETF0.01%28/02/2026
WSMLiShares MSCI World Small-Cap ETF0.01%28/02/2026
DXIVDimensional International Vector Eq ETF0.003%27/02/2026
TLTDFlexShares Mstar DevMks exUS FctTilt ETF0.003%27/02/2026
FLJHFranklin FTSE Japan Hedged ETF0.002%28/02/2026
DEEFXtrackers FTSE Develop ex US Mulfact ETF0.0003%24/02/2026
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%27/02/2026
DLSWisdomTree International SmallCp Div ETF<0.000001%23/10/2025
HSCZiShares Currency Hdgd MSCI EAFE SmCp ETF<0.000001%27/02/2026
JSTCAdasina Social Justice All Cp Glbl ETF<0.000001%28/11/2025
  1   2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.